Device Trial Radar · NCT02143778
Assessing Portal Hypertension With Methacetin Breath Test
Last checked: Nov 20, 2026Latest source record: Dec 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
246
Actual
Start
Nov 2014
Primary completion
Dec 2018
Study completion Jan 2019
Sponsor
- Lead sponsor
- Meridian Bioscience, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 21, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will be used to train an algorithm using Methacetin breath test (MBT) measures and to select a cut-off to determine presence or absence of Clinically Significant Portal Hypertension (CSPH) as defined by Hepatic Venous Gradient Pressure (HVPG) ≥ 10mmHg,
Conditions
- Patients With Compensated Liver Cirrhosis
Interventions
Methacetin Breath TestDevice
13C labelled methacetin solution for breath test monitoring
Primary outcomes
What the sponsor says the trial is designed to measure.
- CSPH (Clinically Significant Portal Hypertension)Time frame: 1 hour
Locations
8 sites in 4 countries. Site status is shown where the registry gives one.
VA Connecticut HealthCare System
New Haven, Connecticut
Duke University Medical Center
Durham, North Carolina
Virginia Commonwealth University
Richmond, Virginia
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.